- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Jun 18, 2018 at 03:43:00)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Jun 19, 2018 | A-150-17 | APP | Nova Chemicals Corp. V. The Dow Chemical Company Et. Al (Patent) | Ottawa | 4 h |
| Jun 19, 2018 | A-227-17 | APP | Nova Chemicals Corp. V. The Dow Chemical Company Et Al (Patent) | Ottawa | 4 h |
| Jun 19, 2018 | T-1338-17 | M | Philip Poyntz Et Al V. Elcargo Fabrication Inc. (Patent) | Toronto | 2 h |
| Jun 19, 2018 | T-1658-17 | M | Janssen Inc V. Apotex Inc Et Al (Patent - Darunavir*) | Toronto | 2 h |
| Jun 19, 2018 | T-222-18 | M | Spin Master Ltd. V. Alpha Group Us, Llc (Patent) | Toronto | 1 h |
| Jun 19, 2018 | T-448-17 | M | Guest Tek Interactive Entertainment Ltd. V. Nomadix, Inc. (Patent) | Toronto | 2 h |
| Jun 19, 2018 | T-226-18 | M | Viiv Healthcare Company Et Al V. Gilead Sciences Canada, Inc. (Patent - DOLUTEGRAVIR*) | Toronto | 2 h |
| Jun 20, 2018 | T-608-17 | CMC | Seedlings Life Science Ventures,llc V. Pfizer Canada Inc. (Patent) | Ottawa | 1 h |
| Jun 20, 2018 | T-641-18 | CMC | Shire Llc And Shire Pharma Canada Ulc V. Apotex Inc. (Patent - Lisdexamfetamine*) | Ottawa | 1 h |
| Jun 21, 2018 | T-1921-17 | M | Genentech Inc Et Al V. Amgen Canada Inc (unknown - Trastuzumab*) | Toronto | 1 d |
| Jun 21, 2018 | T-1645-17 | CMC | Caterpillar Inc. V. Puma Se (Trade Mark) | Toronto | 30 m |
| Jun 22, 2018 | T-724-18 | CMC | Eli Lilly And Company Et Al V. Apotex Inc. (Patent - Teriparatide*) | Ottawa | 1 h |
| Jun 25, 2018 | T-1787-16 | M | Quality Program Services Inc. V. Hmtq In Right Of Ontario (Trade Mark) | Vancouver | 1 d |
| Jun 25, 2018 | T-252-17 | CMC | Richelieu International C. Ass. Des Clubs Richelieu Région Des Fondateurs (Trade Mark) | Ottawa | 1 h |
| Jun 25, 2018 | T-1645-16 | CMC | Arkipelago Architecture Inc. V. Enghouse Systems Limited Et Al (Copyright) | Ottawa | 1 h |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Sep 10, 2018 | T-1930-13 | Tensar Technologies Ltd Et Al V. Enviro-pro Geosynthetics Ltd. (Patent) | Montréal | 10 d |
| Sep 10, 2018 | T-2338-14 | Camso Inc. V. Soucy International Inc. Et Al (Patent) | Montréal | 32 d |
| Oct 1, 2018 | T-1807-11 | Pharmascience Inc. V. Schering-plough Canada Inc. Et Al (PMNOC - Section 8 - Desloratadine*) | Toronto | 20 d |
| Oct 1, 2018 | T-2022-13 | Pyrrha Design Inc. V. Plum And Posey Inc. Et Al (Copyright) | Calgary | 7 d |
| Oct 22, 2018 | T-1056-15 | Western Oilfield Equipment Rentals Ltd V. M-i Llc (Patent) | Calgary | 20 d |
| Nov 5, 2018 | T-1064-13 | Apotex Inc. V. Pfizer Canada Inc. (PMNOC - Section 8 - Latanoprost*) | Toronto | 22 d |
| Nov 5, 2018 | T-393-14 | Apotex Inc. V. Pfizer Inc Et Al (Patent - Latanoprost*) | Toronto | 22 d |
| Nov 19, 2018 | T-1371-16 | Agropur Coopérative C. Parmalat Canada Inc. (Patent) | Ottawa | 10 d |
| Dec 3, 2018 | T-1396-13 | Lantech.com, Llc V. Wulftec International Inc. (Patent) | Montréal | 10 d |
| Dec 12, 2018 | T-1064-13 | Apotex Inc. V. Pfizer Canada Inc. (PMNOC - Section 8 - Latanoprost*) | Toronto | 3 d |
| Dec 12, 2018 | T-393-14 | Apotex Inc. V. Pfizer Inc Et Al (Patent - Latanoprost*) | Toronto | 3 d |
| Jan 28, 2019 | T-598-15 | Specialized Desanders Inc. V. Dynacorp Fabricators Inc. Et Al. (Patent) | Calgary | 10 d |
| Nov 4, 2019 | T-350-18 | Bristol-myers Squibb Canada Co. Et Al V. Apotex Inc. (Patent - Apixaban*) | Toronto | 10 d |
| Nov 4, 2019 | T-351-18 | Bristol-myers Squibb Canada Co. Et Al V. Apotex Inc. (Patent - Apixaban*) | Toronto | 10 d |
| Jan 27, 2020 | T-823-18 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Rituximab*) | Toronto | 10 d |
| Jan 27, 2020 | T-824-18 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Rituximab*) | Toronto | 10 d |
| Jan 27, 2020 | T-825-18 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Rituximab*) | Toronto | 10 d |
| Jan 27, 2020 | T-826-18 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Rituximab*) | Toronto | 10 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Oct 15, 2018 | T-739-17 | Les Laboratoires Servier Et Al C. Apotex Inc. Et Al - Perindopril* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Montréal | 3 d |
| Jan 28, 2019 | T-824-17 | Purdue Pharma V. Collegium Pharmaceutical, Inc. Et Al. - Oxycodone* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 3 d |
| Feb 4, 2019 | T-834-17 | Valeant Canada Lp/valeant Canada S.e.c. V. Generic Partners Canada Inc Et Al - Metformin* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 3 d |
| Apr 1, 2019 | T-830-17 | Allergan Pharma Co., Et.al. V. Minister Of Health Et.al. - Silodosin* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 2 d |
| Apr 1, 2019 | T-1062-17 | Astrazeneca Canada Inc. Et.al. V. Teva Canada Limited Et.al. - Ticagrelor* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 5 d |
| May 13, 2019 | T-1034-17 | Endo Ventures Ltd. Et Al V. Apotex Inc. Et Al - Tapentadol* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 4 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location | Length |
| Jun 19, 2018 | A-150-17 | Nova Chemicals Corp. V. The Dow Chemical Company Et. Al | Appeal (S.27 - Final) - Patent Act | Ottawa | 4 h |
| Jun 19, 2018 | A-227-17 | Nova Chemicals Corp. V. The Dow Chemical Company Et Al | Appeal (S.27 - Final) - Patent Act | Ottawa | 4 h |
| Jun 26, 2018 | A-137-17 | Apotex Inc. V. Minister Of Health Et.al. | Appeal (S.27 - Final) - Others [from T-1915-15 - S. 18.1 Patented Medicines (Notice of Compliance) Regulations] | Toronto | 1.3 d |
| Jun 27, 2018 | A-395-16 | Arctic Cat Inc Et Al V. Bombardier Recreational Products Inc. | Appeal (S.27 - Final) - Patent Act [from T-1353-13 - Patent Infringement] | Ottawa | 4 h |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.